Triton Biosciences, Inc.
Country not established
- Devices
- 1
What Triton Biosciences, Inc. makes
Triton Biosciences, Inc. manufactures the MAK-6 monoclonal anti-cytokeratin cocktail, a diagnostic reagent used for identifying cytokeratin proteins in tissue samples, typically for immunohistochemical analysis.
The company’s portfolio is regulated under FDA’s Class II device classification and is listed via 510(k) premarket notifications. Triton Biosciences, Inc. is based in the United States.
Catalogue
Mak-6 Monoclonal Anti-Cytokeratin Cocktail Ref K881259
510(k) 510(k)
Frequently asked questions
How many devices does Triton Biosciences, Inc. have in the registry?
The registry currently lists 1 device for Triton Biosciences, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Triton Biosciences, Inc.'s devices?
Among its 1 most recently registered device, Triton Biosciences, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Triton Biosciences, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Triton Biosciences, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Triton Biosciences, Inc. in the registry?
The most recently registered devices listed for Triton Biosciences, Inc. include MAK-6 MONOCLONAL ANTI-CYTOKERATIN COCKTAIL.